429 Long-term analysis of MASTERKEY-265 phase 1b trial of talimogene laherparepvec (T-VEC) plus pembrolizumab in patients with unresectable stage IIIB-IVM1c melanoma
| Autor: | Antoni Ribas, Olivier Michielin, Reinhard Dummer, Scott Diede, Salvador Martin-Algarra, Sheryl Treichel, Edward Chan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2020-SITC2020.0429 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|